http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109336776-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H10K85-631
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L51-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-86
filingDate 2018-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109336776-B
titleOfInvention A kind of large sterically hindered alkoxy substituted conjugated compound with triarylamine as end group and its application
abstract A large sterically hindered alkoxy-substituted conjugated compound with triarylamine as an end group relates to the field of organic synthesis, and its structural formula I is as follows: Wherein, Ar is phenyl, naphthyl or anthracenyl, R 1 is H, CH 3 or OCH 3 , and R 2 is a large sterically hindered alkoxy chain. In the present invention, organic triarylamines with better stability are selected as redox active end groups, and conjugated ligands wrapped with dendritic alkoxy groups are used as bridge chains to synthesize compounds attached to large sterically hindered alkoxy chains. It can be seen from electrochemical experiments that the end groups of the triarylamine conjugated compound in the present invention have extremely strong electronic interaction and better charge transport capability, and are particularly suitable for use in insulated molecular wires.
priorityDate 2018-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6107038-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107275519-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016072691-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014138628-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451127074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426177745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426243449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11412342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141742366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414870519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394891
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11979704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20612855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415662935

Total number of triples: 45.